Download file (447KB)
Download as zip (380KB)

コレクション

引用

説明:

Single-strand oligodeoxynucleotides (ODNs) containing unmethylated cytosine-phosphate-guanine (CpG) are recognized by the toll-like receptor 9, a component of the innate immunity. Therefore, they could act as immunotherapeutic agents. Chemically modified CpG ODNs containing a phosphorothioate backbone instead of phosphodiester (PD) were developed as immunotherapeutic agents resistant to nuclease degradation. However, they cause adverse side effects, and so there is a necessity to generate novel CpG ODNs. In the present study, we designed a nuclease-resistant nonmodified CpG ODN that forms G-quadruplex structures. G-quadruplex formation in CpG ODNs increased nuclease resistance and cellular uptake. The CpG ODNs designed in this study induced interleukin-6 production in a human B lymphocyte cell line and human peripheral blood mononuclear cells. These results indicate that G-quadruplex formation can be used to increase the immunostimulatory activity of CpG ODNs having a natural PD backbone.

権利情報:

キーワード: IL-6, toll-like receptor 9, CpG ODN, G-quadruplex, peripheral blood mononuclear cells

刊行年月日: 2019-03-05

出版者: Mary Ann Liebert

掲載誌:

研究助成金:

原稿種別: 査読前原稿 (Author's original)

MDR DOI: https://doi.org/10.48505/nims.1443

公開URL: https://doi.org/10.1089/nat.2018.0761

関連資料:

その他の識別子:

連絡先:

更新時刻: 2024-01-05 22:13:10 +0900

MDRでの公開時刻: 2021-08-13 01:20:03 +0900